» Articles » PMID: 16314924

Understanding Microtubule Dynamics for Improved Cancer Therapy

Overview
Publisher Springer
Specialty Biology
Date 2005 Nov 30
PMID 16314924
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Microtubules (MTs), key components of the cytoskeleton, are dynamic polymers of tubulin that form a well-organized network of polarized tube filaments. MT dynamics are highly regulated both spacially and temporally by several MT-related proteins, themselves regulated by several kinases and phosphatases via signaling cascades, and also by coordinated interactions with actin cytoskeleton and adhesion sites. Regulation of MT dynamics is crucial for mitosis, cell migration, cell signaling and trafficking. MT-targeted drugs (MTDs), which constitute a major anticancer drug family with antimitotic and antiangiogenic properties, inhibit tumor progression mainly by altering MT dynamics in both cancer and endothelial cells. Identification of proteins regulating the MT network will lead to a better understanding of tumor progression regulators and will be helpful in improving cancer therapy.

Citing Articles

1,2,3-Triazole Hybrids Containing Isatins and Phenolic Moieties: Regioselective Synthesis and Molecular Docking Studies.

Maiuolo L, Tallarida M, Meduri A, Fiorani G, Jiritano A, De Nino A Molecules. 2024; 29(7).

PMID: 38611835 PMC: 11013233. DOI: 10.3390/molecules29071556.


Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel.

Ahmed M, Semreen A, Giddey A, Ramadan W, El-Awady R, Soares N Ann Med. 2024; 55(2):2305308.

PMID: 38253025 PMC: 10810643. DOI: 10.1080/07853890.2024.2305308.


Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.

Yang Z, Liu Z, Ablise M, Maimaiti A, Aihaiti A, Alimujiang Y Molecules. 2023; 28(23).

PMID: 38067428 PMC: 10707934. DOI: 10.3390/molecules28237697.


Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell Function.

Thammathong J, Chisam K, Tessmer G, Womack C, Sidrak M, Weissmiller A ACS Med Chem Lett. 2023; 14(9):1284-1294.

PMID: 37736192 PMC: 10510670. DOI: 10.1021/acsmedchemlett.3c00298.


Design, synthesis and anticancer activity of N-aryl indolylsulfoximines: Identification of potent and selective anticancer agents.

Malik M, Kumar D, Lotana H, Shah K, Kumar D Bioorg Med Chem. 2023; 93:117459.

PMID: 37659217 PMC: 10728769. DOI: 10.1016/j.bmc.2023.117459.